WallStSmart

Bentley Systems Inc (BSY)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Bentley Systems Inc generates 480% more annual revenue ($1.50B vs $258.90M). BSY leads profitability with a 18.5% profit margin vs -15.5%. BSY earns a higher WallStSmart Score of 62/100 (C+).

BSY

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 7.5Value: 6.0Quality: 3.8
Piotroski: 5/9Altman Z: 0.90

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSYUndervalued (+32.4%)

Margin of Safety

+32.4%

Fair Value

$50.18

Current Price

$32.84

$17.34 discount

UndervaluedFair: $50.18Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSY2 strengths · Avg: 8.5/10
Return on EquityProfitability
24.9%9/10

Every $100 of equity generates 25 in profit

Operating MarginProfitability
20.7%8/10

Strong operational efficiency at 20.7%

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BSY4 concerns · Avg: 3.5/10
PEG RatioValuation
1.594/10

Expensive relative to growth rate

P/E RatioValuation
38.6x4/10

Premium valuation, high expectations priced in

Price/BookValuation
8.6x4/10

Trading at 8.6x book value

Altman Z-ScoreHealth
0.902/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BSY

The strongest argument for BSY centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.5% and operating margin at 20.7%. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BSY

The primary concerns for BSY are PEG Ratio, P/E Ratio, Price/Book.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

BSY profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BSY scores higher overall (62/100 vs 41/100), backed by strong 18.5% margins and 11.9% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bentley Systems Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Bentley Systems, Incorporated, provides infrastructure engineering software solutions in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The company is headquartered in Exton, Pennsylvania.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?